{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:44:48Z","timestamp":1778507088228,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.nbd.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T12:19:03Z","timestamp":1108988343000},"page":"273-282","source":"Crossref","is-referenced-by-count":23,"title":["Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q"],"prefix":"10.1016","volume":"19","author":[{"given":"Robert","family":"Veerhuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Boshuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Morbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Mazzoleni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen J.M.","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes P.M.","family":"Langedijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Tagliavini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.M.","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Eikelenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1097\/00001756-200108080-00059","article-title":"Killing of prion-damaged neurones by microglia","volume":"12","author":"Bate","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/00001756-200209160-00025","article-title":"Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation","volume":"13","author":"Bate","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.4049\/jimmunol.166.11.6735","article-title":"Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis","volume":"166","author":"Bharadwaj","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ab.2004.06.011","article-title":"An in vitro screening assay based on synthetic prion protein peptides for identification of fibril interfering compounds","volume":"333","author":"Boshuizen","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0161-5890(86)90003-9","article-title":"Evidence for the binding of human serum amyloid P component to C1q and Fab","volume":"23","author":"Bristow","year":"1986","journal-title":"Molec. Immunol."},{"key":"10.1016\/j.nbd.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/380345a0","article-title":"Role of microglia and host prion protein in neurotoxicity of a prion protein fragment","volume":"380","author":"Brown","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1385-299X(99)00059-8","article-title":"Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue","volume":"5","author":"De Groot","year":"2000","journal-title":"Brain Res. Protoc."},{"key":"10.1016\/j.nbd.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/glia.10146","article-title":"Neuroinflammation in Alzheimer and prion disease","volume":"40","author":"Eikelenboom","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"25692","DOI":"10.1074\/jbc.M100133200","article-title":"The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106\u2013126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase","volume":"276","author":"Fabrizi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/362543a0","article-title":"Neurotoxicity of a prion protein fragment","volume":"362","author":"Forloni","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1750-3639.1998.tb00167.x","article-title":"Role of microglia in neuronal cell death in prion disease","volume":"8","author":"Giese","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1006\/nbdi.2000.0316","article-title":"Neurotoxicity of the putative transmembrane domain of the prion protein","volume":"7","author":"Ha\u00efk","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.4049\/jimmunol.149.11.3689","article-title":"Serum amyloid P component binds to histones and activates the classical complement pathway","volume":"149","author":"Hicks","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-3083.2000.00775.x","article-title":"Localization of human serum amyloid P component and heparan sulfate proteoglycan in in vitro-formed Abeta fibrils","volume":"52","author":"Holm Nielsen","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.nbd.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<227::AID-PATH174>3.0.CO;2-3","article-title":"Prion diseases in man","volume":"186","author":"Ironside","year":"1998","journal-title":"J. Pathol."},{"key":"10.1016\/j.nbd.2005.01.005_bib16","first-page":"370","article-title":"The presence of complements in amyloid plaques of Creutzfeldt\u2013Jakob disease and Gerstmann\u2013Straussler\u2013Scheinker disease","volume":"2","author":"Ishii","year":"1984","journal-title":"Appl. Pathol."},{"key":"10.1016\/j.nbd.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2990.1991.tb00714.x","article-title":"Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders","volume":"17","author":"Kalaria","year":"1991","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/exnr.1995.1051","article-title":"Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia","volume":"134","author":"Korotzer","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2003.09.010","article-title":"Complement activation in human prion disease","volume":"15","author":"Kovacs","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00001756-199903170-00012","article-title":"Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines","volume":"10","author":"Peyrin","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2005.01.005_bib23","article-title":"Microglia and complement in the cortex of Creutzfeldt\u2013Jakob disease and comparison with Alzheimer's disease","volume":"658","author":"Rozemuller","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2005.01.005_bib24","doi-asserted-by":"crossref","first-page":"48146","DOI":"10.1074\/jbc.M307295200","article-title":"Structural properties of Gerstmann\u2013Straussler\u2013Scheinker disease amyloid protein","volume":"278","author":"Salmona","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00369445","article-title":"Immunohistochemical study of microglia in the Creutzfeldt\u2013Jakob diseased brain","volume":"86","author":"Sasaki","year":"1993","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2005.01.005_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/exnr.1994.1121","article-title":"Complement C1q does not bind to monomeric \u03b2-amyloid","volume":"128","author":"Snyder","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.01.005_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(99)11419-3","article-title":"Reversion of prion protein conformational changes by synthetic \u03b2-sheet breaker peptides","volume":"355","author":"Soto","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2005.01.005_bib28","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1073\/pnas.90.20.9678","article-title":"Synthetic peptides homologous to prion protein residues 106\u2013147 form amyloid-like fibrils in vitro","volume":"90","author":"Tagliavini","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2005.01.005_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2005.01.005_bib30","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","article-title":"Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis","volume":"92","author":"Tennent","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2005.01.005_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4049\/jimmunol.127.2.648","article-title":"Purification and radiolabeling of human C1q","volume":"127","author":"Tenner","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2005.01.005_bib32","first-page":"525","article-title":"Serum amyloid P component enhances induction of murine amyloidosis","volume":"77","author":"Togashi","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.nbd.2005.01.005_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/exnr.1999.7199","article-title":"Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-Inhibitor","volume":"160","author":"Veerhuis","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.01.005_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(01)03273-5","article-title":"Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2","volume":"925","author":"Veerhuis","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2005.01.005_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00401-002-0624-7","article-title":"Amyloid \u03b2-associated proteins C1q and SAP enhance the A\u03b21-42 peptide-induced cytokine secretion by adult human microglia in vitro","volume":"105","author":"Veerhuis","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2005.01.005_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jnr.490390412","article-title":"Enhanced aggregation and \u03b2 structure of amyloid \u03b2 peptide after coincubation with C1q","volume":"39","author":"Webster","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2005.01.005_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0006-8993(94)90480-4","article-title":"Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice","volume":"654","author":"Williams","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2005.01.005_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/exnr.1997.6424","article-title":"PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie","volume":"144","author":"Williams","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.01.005_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(97)00067-X","article-title":"Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations","volume":"754","author":"Williams","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2005.01.005_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4049\/jimmunol.150.1.169","article-title":"Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14\u201326 and 76\u201392 of the A chain collagen-like region of C1q","volume":"150","author":"Ying","year":"1993","journal-title":"J. Immunol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996105000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996105000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T07:36:08Z","timestamp":1683012968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996105000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0969996105000094"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2005.01.005","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}